Application of microRNAs in diagnosis and treatment of cardiovascular disease

A. Wronska, I. Kurkowska-Jastrzebska, G. Santulli

Research output: Contribution to journalReview article

98 Scopus citations

Abstract

Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. Innovative, more stringent diagnostic and prognostic biomarkers and effective treatment options are needed to lessen its burden. In recent years, microRNAs have emerged as master regulators of gene expression – they bind to complementary sequences within the mRNAs of their target genes and inhibit their expression by either mRNA degradation or translational repression. microRNAs have been implicated in all major cellular processes, including cell cycle, differentiation and metabolism. Their unique mode of action, fine-tuning gene expression rather than turning genes on/off, and their ability to simultaneously regulate multiple elements of relevant pathways makes them enticing potential biomarkers and therapeutic targets. Indeed, cardiovascular patients have specific patterns of circulating microRNA levels, often early in the disease process. This article provides a systematic overview of the role of microRNAs in the pathophysiology, diagnosis and treatment of CVD.

Original languageEnglish (US)
Pages (from-to)60-83
Number of pages24
JournalActa Physiologica
Volume213
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Keywords

  • atherosclerosis
  • biomarkers
  • cardiovascular disease
  • microRNA

ASJC Scopus subject areas

  • Physiology

Fingerprint Dive into the research topics of 'Application of microRNAs in diagnosis and treatment of cardiovascular disease'. Together they form a unique fingerprint.

  • Cite this